Carter Bankshares (CARE) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
5 Nov, 2026Executive summary
FY2023 net income was $23.4M, down 53.3% YoY; Q4 posted a $1.9M net loss and diluted loss per share of $0.08.
A $301.9M lending relationship placed on nonaccrual in Q2 reduced FY2023 interest income by $30.0M.
Financial highlights
Q4 net interest income was $27.4M, flat QoQ and down 34.0% YoY; FY net interest income fell 12.6% to $122.3M.
Q4 noninterest income was $3.2M and included a $1.5M securities-sale loss; FY noninterest income declined 15.8% to $18.3M.
Q4 noninterest expense was $29.1M; FY expense rose 8.7% to $105.5M, driven by compensation, FDIC insurance and other costs.
Year-end assets were $4.51B, up 7.3% YoY; shareholders’ equity was $351.2M, up $22.6M.
Outlook and guidance
Lending pipelines moderated, but near-term loan growth was expected to remain respectable; funding-cost pressure was viewed as beginning to stabilize.
NIM was expected to normalize after resolution of the large nonaccrual relationship; the $1.5M securities-sale loss was expected to be earned back in less than one year.
79.7% of time deposits were set to mature and reprice within 12 months, creating flexibility to manage deposit pricing if short-term rates declined in 2024.
Strategic priorities included diversified, attractively priced lending, reducing CRE concentration, expanding C&I and consumer lending, and growing share in target markets.
Latest events from Carter Bankshares
- Higher net interest income lifted 2022 earnings as loans grew and deposits and equity faced pressure.CARE
Q4 2022 - NIM expansion and loan growth offset elevated quarterly credit costs.CARE
Q3 2026 - Net income surged on nonrecurring gains, with improved asset quality and capital ratios.CARE
Q2 2026 - Earnings surged in Q1 2026 on a major loan sale, sharply improving capital and asset quality amid new legal risks.CARE
Q1 2026 - Director elections, executive pay, auditor ratification, and ESG priorities headline the 2026 proxy.CARE
Proxy filing - Votes will be cast on director elections, executive pay, and auditor ratification for 2026.CARE
Proxy filing - Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 2025 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 2025